Fragment-based drug discovery (FBDD) has emerged as a rigorous and efficient strategy for identifying lead compounds against structurally defined biological ...

Virtual screening is a computational approach used to identify chemical structures that are predicted to have particular properties. For example, in the context of drug discovery, it may involve ...

Scientists at the Icahn School of Medicine at Mount Sinai have uncovered the first high-resolution structure of NBCn2, a brain protein linked to epilepsy, autism spectrum disorder and other ...

Scientists at the Icahn School of Medicine at Mount Sinai have uncovered the first high-resolution structure of NBCn2, a brain protein linked to epilepsy, autism spectrum disorder, and other ...

Dong-A Socio Group announced on the 29th that its IT subsidiary DAI and Dong-A ST have built the AI Drug Discovery Platform ...

Key opportunities in AI-driven materials discovery include increasing demand for rapid advanced materials development, growth in AI-based modeling adoption, and collaborations between academia and ...

Available through the NVIDIA BioNeMo Agent Toolkit, advancing drug discovery where AI agents and researchers work ...

As generative AI captures public attention, a different kind of AI is reshaping drug discovery. Machine learning models are ...

I want to thank you for joining NAVREF for today's discussion on the future of lung cancer screening for veterans. My name is Rashi Romanoff. I am the CEO of the National Association for Veterans ...

AI used to have distinguishable tells that separated real from fake. Now, dangerous AI arrives authorized, and the old tells ...

During structure-based virtual screening, the TRPV6 protein was treated as a rigid structure. Conversely, small molecules in the compound library generate numerous compound structures with different ...